Join the Assessment Waitlist
Lenire is now available in the United States of America following a landmark clinical study that demonstrated the safety and efficacy of Lenire. Lenire was granted De Novo approval by the United States of America Food and Drug Administration (FDA).
To ensure all Lenire patients receive the highest quality of care, we are presently training tinnitus specialists across the United States with our novel tinnitus treatment technology.
Once they have completed their training, we will pass your request to your nearest Lenire provider and they will contact you directly to arrange your appointment.
Thank you for your patience and for your interest in Lenire.